Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Queensland Health
Citi
Daiichi Sankyo
Federal Trade Commission
Cipla
Julphar
Cantor Fitzgerald
AstraZeneca

Generated: August 23, 2017

DrugPatentWatch Database Preview

ORA-TESTRYL Drug Profile

« Back to Dashboard

Which patents cover Ora-testryl, and when can generic versions of Ora-testryl launch?

Ora-testryl is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in ORA-TESTRYL is fluoxymesterone. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluoxymesterone profile page.

Summary for Tradename: ORA-TESTRYL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list25
Clinical Trials: see list10
Patent Applications: see list5,337
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORA-TESTRYL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
ORA-TESTRYL
fluoxymesterone
TABLET;ORAL011359-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
ORA-TESTRYL
fluoxymesterone
TABLET;ORAL011359-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Deloitte
Chinese Patent Office
Express Scripts
Accenture
Baxter
Citi
Covington
AstraZeneca
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot